Literature DB >> 16352630

TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45.

Paul J Bryce1, Michiko K Oyoshi, Seiji Kawamoto, Hans C Oettgen, Erdyni N Tsitsikov.   

Abstract

We have previously reported that tumor necrosis factor receptor-associated factor 1 (TRAF1), an intracellular protein, which binds to a range of molecules, including tumor necrosis factor (TNF) receptor family members, regulates TNF-induced NF-kappaB and AP-1 signaling as well as TCR-triggered proliferative responses in T cells. In order to define the role of TRAF1 in Th cell differentiation, we analyzed the responses of TRAF1-/- T cells following TCR activation. Stimulation of TRAF1-/- T cells by antigen resulted in significantly increased expression of the Th2 cytokines (IL-4, IL-5 and IL-13) compared with wild-type (WT) controls. The Th2 bias of TRAF1-/- T cells is T lymphocyte intrinsic, since naive CD4+CD62L+ TRAF1-/- T cells activated with CD3/CD28 produced elevated levels of Th2 cytokines. Consistent with these observations in cultured T cells, TRAF1-/- T cells induced enhanced Th2 responses in vivo. Transfer of ovalbumin (OVA)-immune TRAF1-/- T cells into naive WT recipients conferred significantly more intense pulmonary inflammation and higher airway hyperresponsiveness following inhaled OVA challenge than did transfer of OVA-immune WT T cells. Biochemical analysis of TRAF1-/- T cells revealed that they have elevated nuclear expression of NFAT-interacting protein (NIP45), a Th2 cell-associated transcription factor known to potentiate NFATp-driven IL-4 expression. In further experiments, we demonstrated that TRAF1 associates with a fraction of NIP45 in the cytoplasm and prevents its translocation to the nucleus. Taken together these results suggest that TRAF1 may limit the induction of Th2 responses by decreasing NIP45 concentration to the nucleus and thereby down-regulating the expression of NIP45-dependent IL-4 gene transcription.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352630     DOI: 10.1093/intimm/dxh354

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 2.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

3.  NIP45 negatively regulates RANK ligand induced osteoclast differentiation.

Authors:  Srinivasan Shanmugarajan; Courtney J Haycraft; Sakamuri V Reddy; William L Ries
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

4.  Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.

Authors:  Anna Missiou; Natascha Köstlin; Nerea Varo; Philipp Rudolf; Peter Aichele; Sandra Ernst; Christian Münkel; Carina Walter; Peter Stachon; Benjamin Sommer; Dietmar Pfeifer; Katja Zirlik; Lindsey MacFarlane; Dennis Wolf; Erdyni Tsitsikov; Christoph Bode; Peter Libby; Andreas Zirlik
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

5.  Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma.

Authors:  Hiam Abdala-Valencia; Julie Earwood; Shelly Bansal; Michael Jansen; George Babcock; Beth Garvy; Marsha Wills-Karp; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-02-09       Impact factor: 5.464

Review 6.  Asthma and the Missing Heritability Problem: Necessity for Multiomics Approaches in Determining Accurate Risk Profiles.

Authors:  Tracy Augustine; Mohammad Ameen Al-Aghbar; Moza Al-Kowari; Meritxell Espino-Guarch; Nicholas van Panhuys
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

7.  A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.

Authors:  Angela C Boroughs; Rebecca C Larson; Nemanja D Marjanovic; Kirk Gosik; Ana P Castano; Caroline B M Porter; Selena J Lorrey; Orr Ashenberg; Livnat Jerby; Matan Hofree; Gabriela Smith-Rosario; Robert Morris; Joshua Gould; Lauren S Riley; Trisha R Berger; Samantha J Riesenfeld; Orit Rozenblatt-Rosen; Bryan D Choi; Aviv Regev; Marcela V Maus
Journal:  Mol Ther       Date:  2020-07-25       Impact factor: 11.454

8.  Rational targeting Cdc42 restrains Th2 cell differentiation and prevents allergic airway inflammation.

Authors:  Jun-Qi Yang; Khalid W Kalim; Yuan Li; Xin Duan; Phuong Nguyen; Gurjit K Khurana Hershey; John Kroner; Brandy Ruff; Li Zhang; Nathan Salomonis; Mark Rochman; Ting Wen; Yi Zheng; Fukun Guo
Journal:  Clin Exp Allergy       Date:  2018-11-13       Impact factor: 5.018

9.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

10.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.